申请人:Boehringer Ingelheim International GmbH
公开号:US20210387963A1
公开(公告)日:2021-12-16
Disclosed are phenyltetrazole derivatives of formula (I),
wherein A, R
1
, R
2
, X, R′, R″, and n are as defined herein, and pharmaceutically acceptable salts thereof. Also disclosed are methods of using the phenyltetrazole derivatives for the treatment of diseases which can be influenced by inhibition of plasma kallikrein.